Basic Information
ID: ALA4818112
Type: Binding
Description: Inhibition of SARS-CoV-2 main protease at 50 uM using Dabcy1-KTSAVLQSGFRKM-E-Edans-NH2 as substrate incubated for 10 mins followed by substrate addition by FRET assay relative to control
Organism: Severe acute respiratory syndrome coronavirus 2
Activity Charts
Bioactivity
Activity Types for Assay ALA4818112
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 385.43 | 4.46 | 4.46 |
| 399.41 | 3.15 | 3.15 |
| 396.41 | 3.92 | 3.92 |
| 383.46 | 4.21 | 4.21 |
| 388.40 | 4.80 | 4.80 |
| 382.42 | 3.18 | 3.18 |
| 389.47 | 4.41 | 4.41 |
| 387.83 | 4.62 | 4.62 |
| 399.84 | 2.02 | 2.02 |
| 395.37 | 4.16 | 4.16 |
| 397.48 | 3.47 | 3.47 |
| 398.38 | 4.09 | 4.09 |
| 390.45 | 4.48 | 4.48 |
| 380.45 | 4.88 | 4.88 |
| 393.45 | 5.14 | 5.14 |
| 395.46 | 4.50 | 4.50 |
| 377.42 | 3.68 | 3.68 |